Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few—in this case, children, adolescents, and young adults. Because its symptoms can ...

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

Get Instant Summarized Text (Gist) Fibrolamellar hepatocellular carcinoma (FLC) is a rare liver cancer affecting young individuals, often misdiagnosed until it metastasizes. It is characterized by ...

Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few-in this case, children, adolescents, and young adults. Because its symptoms ...

Long classified as a subset of common liver cancer, FLC should be considered its own unique disease. Now researchers are testing a combination drug therapy that targets FLC tumors. Like many rare ...

L ike many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few—in this case, children, adolescents, and young adults. Because its ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

New research and a clinical trial offer hope for effective treatments. Fibrolamellar hepatocellular carcinoma (FLC), like many rare diseases, strikes a small but vulnerable group—primarily children, ...

hepatocellular carcinoma (HCC), fibrolamellar carcinoma and rhabdomyosarcoma. It inhibits T cell immunoglobulin mucin-3 (TIM-3). The drug candidate is a humanized monoclonal IgG4 antibody and is ...

DT-2216 is under development for the treatment of solid tumor and hematologic malignancy, fibrolamellar hepatocellular carcinoma, unspecified B-cell lymphomas, small-cell lung cancer, T-cell lymphoma, ...